Biomarin Pharmaceutical reported $786.36M in Stock for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 7.01M 0.87M
Alnylam Pharmaceuticals ALNY:US $ 78.52M 44.18M
Amgen AMGN:US $ 4411M 325M
Bayer BAYN:GR € 10869M 445M
Biogen BIIB:US $ 1215.4M 136.1M
Biomarin Pharmaceutical BMRN:US $ 786.36M 9.69M
Gilead Sciences GILD:US $ 2675M 1057M
IONIS PHARMACEUT IONS:US $ 24.03M 0.77M
Moderna Inc MRNA:US 1.94B 501M
Neurocrine Biosciences NBIX:US $ 29M 1.5M
Ptc Therapeutics PTCT:US $ 15.28M 0.57M
Puma Biotechnology PBYI:US $ 7.28M 0.17M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
Seattle Genetics SGEN:US $ 275.75M 75.08M
Ultragenyx Pharmaceutical RARE:US $ 17.81M 1.58M
United Therapeutics UTHR:US $ 88.2M 5.6M
Vertex Pharmaceuticals VRTX:US $ 338.9M 14.2M
YTE INCY:US $ 35.46M 7.55M